How Serotonin Works: Findings Point to New Treatments for Schizophrenia and Depression, The Scripps Research Institute Study

ScienceDaily (Oct. 5, 2010) — Scripps Research Institute scientists have shown for the first time that the neurotransmitter serotonin uses a specialized signaling pathway to mediate biological functions that are distinct from the signaling pathways used by hallucinogenic substances. The new findings could have a profound effect on the development of new therapies for a number of disorders, including schizophrenia and depression.